Old Web
English
Sign In
Acemap
>
authorDetail
>
Feng Roger Luo
Feng Roger Luo
European Automobile Manufacturers Association
Lung cancer
Medicine
Pathology
Cell
EGFR T790M
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC).
2019
Journal of Clinical Oncology
Qing Zhou
Lin Wu
Luo Feng
Tongtong An
Ying Cheng
Jianying Zhou
Junling Li
Ji-feng Feng
Li Zhang
Baohui Han
Walson Xu
Lvyu Zhu
Li Xu
Xiao Xu
Feng Roger Luo
Yi-Long Wu
Show All
Source
Cite
Save
Citations (4)
The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer
2019
Social Science Research Network
Yi-Chen Zhang
Zhi-Hong Chen
Xu-Chao Zhang
Chong-Rui Xu
Hong-Hong Yan
Zhi Xie
Shao-Kun Chuai
Junyi Ye
Han-Zhang Han
Zhou Zhang
Xiao-Yan Bai
Jian-Su
Bin Gan
Jin-Ji Yang
Wen-Feng Li
Wei Tang
Feng Roger Luo
Xiao Xu
Yi-Long Wu
Qing Zhou
Show All
Source
Cite
Save
Citations (0)
1